News and Trends 3 Nov 2022Trial and new drug for Tourette Syndrome after $250M after funding round completed A phase 3 clinical trial and the potential commercialization of a new class of drug for patients with Tourette Syndrome… November 3, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email